Stempeutics demonstrates capability to produce stem cell based drugs for 10,000+ patients
Stempeutics Research Pvt Ltd, a group company of Manipal Group, has achieved a major breakthrough in stem cell production technology with the manufacture of its Investigational New drug (IND) sourced from Mesenchymal Stem Cells (MSCs) derived from bone marrow of healthy donors.
[Read the full article here]Related News:
Stempeutics to launch its stem cell based new drug in India by 2012
Advanced Cell Technology shares jump on IND filing for stem cell-based therapy trial
Effective inducing systems of hepatic differentiation from bone marrow mesenchymal stem cells